Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 16, Issue 3, 2018, Pages 343-356.e3

  Fumery, Mathurin ^a,b   Singh, Siddharth ^a   Dulai, Parambir S ^a   Gower Rousseau, Corinne ^c   Peyrin Biroulet, Laurent ^d   Sandborn, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Natural History; Population based; Ulcerative Colitis

Indexed keywords

IMMUNOMODULATING AGENT; MESALAZINE; TUMOR NECROSIS FACTOR INHIBITOR; CORTICOSTEROID;

ADULT; AGGRESSION; ARTICLE; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL OUTCOME; COLON RESECTION; COLORECTAL CANCER; CORTICOSTEROID THERAPY; CROHN DISEASE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; INCIDENCE; LONG TERM CARE; MORBIDITY; MORTALITY RATE; PATIENT-REPORTED OUTCOME; PHENOTYPE; PROGNOSIS; RECURRENCE RISK; REMISSION; RISK ASSESSMENT; SURGICAL RISK; SYSTEMATIC REVIEW; TREATMENT PLANNING; ULCERATIVE COLITIS; WOUND HEALING; ADOLESCENT; AGED; DISEASE EXACERBATION; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLITIS, ULCERATIVE; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 85040714529     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.06.016     Document Type: Article

References (76)

1. Cosnes, J., Gower-Rousseau, C., Seksik, P., et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140 (2011), 1785–1794.
2. Molodecky, N.A., Soon, I.S., Rabi, D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54.
3. Bernstein, C.N., Ng, S.C., Lakatos, P.L., et al. A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis 19 (2013), 2001–2010.
4. Kaplan, G.G., Seow, C.H., Ghosh, S., et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 107 (2012), 1879–1887.
5. Peyrin-Biroulet, L., Loftus, E.V. Jr., Colombel, J.F., et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 105 (2010), 289–297.
6. Fumery, M., Duricova, D., Gower-Rousseau, C., et al. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther 43 (2016), 346–355.
7. Booth, C.M., Tannock, I.F., Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110 (2014), 551–555.
8. Szklo, M., Population-based cohort studies. Epidemiol Rev 20 (1998), 81–90.
9. Höie, O., Wolters, F., Riis, L., et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 102 (2007), 1692–1701.
10. Vester-Andersen, M.K., Prosberg, M.V., Jess, T., et al. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol 109 (2014), 705–714.
11. Niewiadomski, O., Studd, C., Hair, C., et al. Prospective population-based cohort of inflammatory bowel disease in the biologics era: disease course and predictors of severity. J Gastroenterol Hepatol 30 (2015), 1346–1353.
12. Samuel, S., Ingle, S.B., Dhillon, S., et al. Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis. Inflamm Bowel Dis 19 (2013), 1858–1866.
13. Vegh, Z., Kurti, Z., Gonczi, L., et al. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease. Scand J Gastroenterol 51 (2016), 848–854.
14. Ng, S.C., Zeng, Z., Niewiadomski, O., et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology 150 (2016), 86–95.
15. Henriksen, M., Jahnsen, J., Lygren, I., et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease—results from a prospective population-based study. Gut 57 (2008), 1518–1523.
16. Romberg-Camps, M.J., Dagnelie, P.C., Kester, A.D., et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 104 (2009), 371–383.
17. Söderlund, S., Brandt, L., Lapidus, A., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 136 (2009), 1561–1567.
18. Solberg, I.C., Lygren, I., Jahnsen, J., et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 44 (2009), 431–440.
19. Witte, J., Shivananda, S., Lennard-Jones, J.E., et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 35 (2000), 1272–1277.
20. Vegh, Z., Burisch, J., Pedersen, N., et al. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis 8 (2014), 1506–1515.
21. Sjöberg, D., Holmström, T., Larsson, M., et al. Incidence and clinical course of Crohn's disease during the first year: results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis 8 (2014), 215–222.
22. Stewénius, J., Adnerhill, I., Ekelund, G.R., et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum 39 (1996), 1019–1025.
23. Jess, T., Riis, L., Vind, I., et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 13 (2007), 481–489.
24. Jakobsen, C., Bartek, J. Jr., Wewer, V., et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: a population-based study. Aliment Pharmacol Ther 34 (2011), 1217–1224.
25. Høie, O., Aamodt, G., Vermeire, S., et al. Serological markers are associated with disease course in ulcerative colitis: a study in an unselected population-based cohort followed for 10 years. J Crohns Colitis 2 (2008), 114–122.
26. Vind, I., Riis, L., Jespersgaard, C., et al. Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. J Crohns Colitis 2 (2008), 162–169.
27. Golovics, P.A., Lakatos, L., Mandel, M.D., et al. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012. World J Gastroenterol 21 (2015), 7272–7280.
28. Leijonmarck, C.E., Löfberg, R., Ost, A., et al. Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County. Dis Colon Rectum 33 (1990), 195–200.
29. Katsanos, K.H., Vermeire, S., Christodoulou, D.K., et al. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Digestion 75 (2007), 113–121.
30. Jess, T., Horváth-Puhó, E., Fallingborg, J., et al. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol 108 (2013), 1869–1876.
31. Hovde, Ø., Småstuen, M.C., Høivik, M.L., et al. Mortality and causes of death in ulcerative colitis: results from 20 years of follow-up in the IBSEN study. Inflamm Bowel Dis 22 (2016), 141–145.
32. Stewénius, Adnerhill, I., Ekelund, G.R., et al. Operations in unselected patients with ulcerative colitis and indeterminate colitis: a long-term follow-up study. Eur J Surg 162 (1996), 131–137.
33. Lakatos, L., Kiss, L.S., David, G., et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 17 (2011), 2558–2565.
34. Frolkis, A.D., Dykeman, J., Negrón, M.E., et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145 (2013), 996–1006.
35. Jeuring, S.F., Bours, P.H., Zeegers, M.P., et al. Disease outcome of ulcerative colitis in an era of changing treatment strategies: results from the Dutch population-based IBDSL cohort. J Crohns Colitis 9 (2015), 837–845.
36. Frøslie, K.F., Jahnsen, J., Moum, B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133 (2007), 412–422.
37. Hoie, O., Wolters, F.L., Riis, L., et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 132 (2007), 507–515.
38. Singh, S., Al-Darmaki, A., Frolkis, A.D., et al. Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology 149 (2015), 928–937.
39. Faubion, W.A. Jr., Loftus, E.V. Jr., Harmsen, W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121 (2001), 255–260.
40. Ekbom, A., Helmick, C., Zack, M., et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323 (1990), 1228–1233.
41. Jess, T., Rungoe, C., Peyrin-Biroulet, L., Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10 (2012), 639–645.
42. Winther, K.V., Jess, T., Langholz, E., et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2 (2004), 1088–1095.
43. Lakatos, L., Mester, G., Erdelyi, Z., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 12 (2006), 205–211.
44. Jess, T., Loftus, E.V. Jr., Velayos, F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 130 (2006), 1039–1046.
45. Manninen, P., Karvonen, A.L., Huhtala, H., et al. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. J Crohns Colitis 7 (2013), e551–e557.
46. Palli, D., Trallori, G., Saieva, C., et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut 42 (1998), 175–179.
47. Karlén, P., Löfberg, R., Broström, O., et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94 (1999), 1047–1052.
48. Yadav, S., Singh, S., Harmsen, W.S., et al. Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from Olmsted County, Minnesota. Mayo Clin Proc 90 (2015), 738–746.
49. Pedersen, N., Duricova, D., Elkjaer, M., et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol 105 (2010), 1480–1487.
50. Graff, L.A., Vincent, N., Walker, J.R., et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 17 (2011), 1882–1889.
51. Romberg-Camps, M.J., Bol, Y., Dagnelie, P.C., et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands—the IBD-South Limburg cohort. Inflamm Bowel Dis 16 (2010), 2137–2147.
52. Burisch, J., Weimers, P., Pedersen, N., et al. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease: an ECCO-EpiCom study. J Crohns Colitis 8 (2014), 1030–1042.
53. Bernklev, T., Jahnsen, J., Schulz, T., et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol 17 (2005), 1037–1045.
54. Israeli, E., Graff, L.A., Clara, I., et al. Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis. Clin Gastroenterol Hepatol 12 (2014), 1330–1337.e2.
55. Høivik, M.L., Moum, B., Solberg, I.C., et al. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62 (2013), 368–375.
56. Höie, O., Schouten, L.J., Wolters, F.L., et al. Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 56 (2007), 497–503.
57. Hovde, Ø., Småstuen, M.C., Høivik, M.L., et al. Mortality and causes of death in ulcerative colitis: results from 20 years of follow-up in the IBSEN Study. Inflamm Bowel Dis 22 (2016), 141–145.
58. Romberg-Camps, M., Kuiper, E., Schouten, L., et al. Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study—the IBD South-Limburg cohort. Inflamm Bowel Dis 16 (2010), 1397–1410.
59. Masala, G., Bagnoli, S., Ceroti, M., et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut 53 (2004), 1309–1313.
60. Manninen, P., Karvonen, A.L., Huhtala, H., et al. Mortality in ulcerative colitis and Crohn's disease: a population-based study in Finland. J Crohns Colitis 6 (2012), 524–528.
61. Jess, T., Loftus, E.V. Jr., Harmsen, W.S., et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55 (2006), 1248–1254.
62. Persson, P.G., Bernell, O., Leijonmarck, C.E., et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 110 (1996), 1339–1345.
63. Isene, R., Bernklev, T., Høie, O., et al. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 50 (2015), 300–305.
64. Palm, Ø., Moum, B., Jahnsen, J., et al. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) 40 (2001), 1256–1261.
65. Shivashankar, R., Loftus, E.V. Jr., Tremaine, W.J., et al. Incidence of spondyloarthropathy in patients with ulcerative colitis: a population-based study. J Rheumatol 40 (2013), 1153–1157.
66. Yadav, S., Singh, S., Edakkanambeth Varayil, J., et al. Hidradenitis suppurativa in patients with inflammatory bowel disease: a population-based cohort study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 14 (2016), 65–70.
67. Høivik, M.L., Reinisch, W., Cvancarova, M., et al. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther 39 (2014), 69–76.
68. Sjöberg, D., Holmström, T., Larsson, M., et al. Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis 20 (2014), 2266–2270.
69. Ott, C., Liebold, A., Takses, A., et al. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract, 2012, 2012, 595970.
70. Loftus, E.V. Jr., Achenbach, S.J., Sandborn, W.J., et al. Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol 1 (2003), 465–473.
71. Leslie, W.D., Miller, N., Rogala, L., et al. Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Inflamm Bowel Dis 15 (2009), 39–46.
72. Isene, R., Bernklev, T., Høie, O., et al. Thromboembolism in inflammatory bowel disease: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 49 (2014), 820–825.
73. Vegh, Z., Golovics, P.A., Lovasz, B.D., et al. Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort. Scand J Gastroenterol 50 (2015), 306–311.
74. Stewénius, J., Adnerhill, I., Anderson, H., et al. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö. Sweden. Int J Colorectal Dis 10 (1995), 117–122.
75. Lakatos, P.L., Lovasz, B.D., David, G., et al. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. J Crohns Colitis 7 (2013), 385–391.
76. Colombel, J.F., Narula, N., Peyrin-Biroulet, L., Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology 152 (2017), 351–361.e5.